The Citizen on MSN3h
First HIV cure clinical trial in Africa shows promise in womenDar/Nairobi. A ground-breaking HIV clinical trial in Africa has demonstrated that some women can control the virus without ...
The clinical trial, dubbed FRESH and conducted in Durban, South Africa, revealed that four out of 20 women with acute HIV ...
Verywell Health on MSN2d
HIV vs. AIDS: How They Differ and Why Early Treatment MattersPeople with AIDS also have HIV, as HIV is the first stage of AIDS. Learn about the differences, how the conditions overlap, ...
Soquelitinib Atopic Dermatitis Phase 1 Clinical Trial Data From Cohorts 1-3 anticipated to be Presented in MayInitial Results From First Two ...
During infections, the immune system needs to distinguish foreign antigens that are expressed by invading bacteria and ...
The presence of anti-CD4 autoantibodies in treatment-naive patients with advanced HIV was associated with a decreased rate of CD4 reconstitution following ART initiation.
News Medical on MSN2d
Study reveals key role of Treg cells in preventing autoimmune responsesDuring infections, the immune system needs to distinguish foreign antigens that are expressed by invading bacteria and viruses from self-antigens that are expressed by cells of the body.
New research shows how a specially trained population of immune cells keeps the peace by preventing other immune cells from attacking their own. The study provides a better understanding of immune ...
MedPage Today on MSN14d
Broadly Neutralizing Antibodies Delayed Rebound in HIV Patients Who Stopped ARTSAN FRANCISCO -- Most patients with HIV who received two broadly neutralizing antibodies (bNAbs) after pausing antiretroviral ...
Gilead's CROI 2025 data highlights Biktarvy's sustained HIV/HBV suppression, lenacapavir's efficacy, and vesatolimod's safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback